Femasys Partners with AMI Technologies for Fertility Portfolio in Israel
Femasys announced a strategic partnership with AMI Technologies to introduce and commercialize its fertility portfolio in Israel. This collaboration marks an important step in the Company's global expansion strategy and is expected to broaden international market access and drive adoption of innovative technologies, including FemaSeed as a first-line infertility treatment and FemVue for ultrasound diagnosis of tubal factors.
